| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.063 | 14.171 | 10.343 | 7.884 | 4.237 | 3.851 | 11.743 | 5.575 | 3.698 | 6.965 |
| Total Income - EUR | 3.099 | 14.171 | 10.509 | 7.890 | 4.312 | 3.863 | 11.843 | 5.609 | 3.698 | 7.990 |
| Total Expenses - EUR | 2.611 | 3.419 | 2.678 | 2.160 | 2.239 | 2.347 | 1.948 | 2.022 | 2.198 | 2.420 |
| Gross Profit/Loss - EUR | 489 | 10.752 | 7.831 | 5.730 | 2.073 | 1.516 | 9.895 | 3.587 | 1.499 | 5.570 |
| Net Profit/Loss - EUR | 395 | 10.327 | 7.516 | 5.493 | 1.944 | 1.400 | 9.540 | 3.419 | 1.388 | 5.331 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - New Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 867 | 10.531 | 14.247 | 7.749 | 3.186 | 4.611 | 9.865 | 12.939 | 1.998 | 7.451 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 6.328 | 1.176 | 0 | 174 | 0 | 0 | 0 | 188 |
| Cash | 867 | 10.531 | 7.920 | 6.573 | 3.186 | 4.437 | 9.865 | 12.939 | 1.998 | 7.263 |
| Shareholders Funds | 444 | 10.376 | 7.564 | 5.541 | 1.990 | 1.445 | 9.584 | 3.464 | 1.433 | 5.375 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 423 | 156 | 6.684 | 2.208 | 1.196 | 3.166 | 281 | 9.475 | 565 | 2.076 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - New Med S.r.l.